Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 64, Issue 1, 2006, Pages 26-32

  Sebti, Thami ^a   Pilcer, Gabrielle ^a   Van Gansbeke, Bernard ^b   Goldman, Serge ^b   Michils, Alain ^b   Vanderbist, Francis ^c   Amighi, Karim ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Laboratoires SMB SA   (Belgium)

Author keywords

Dry powder inhaler; Gamma scintigraphy; Pharmacokinetics; Solid lipid particles; Total and regional lung deposition

Indexed keywords

BUDESONIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; DRY POWDER; EVALUATION; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MALE; PARTICLE SIZE; POWDER INHALER; RANDOMIZED CONTROLLED TRIAL;

ABSORPTION; ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; BUDESONIDE; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; HUMANS; INHALATION; LIPIDS; LUNG; MALE; NEBULIZERS AND VAPORIZERS; POWDERS; RADIONUCLIDE IMAGING; RESPIRATORY FUNCTION TESTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 33746480274     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.03.005     Document Type: Article

References (19)

1. Pitcairn G.R., Hooper G., Luria X., Rivero X., and Newman S.P. A scintigraphic study to evaluate the deposition patterns of a novel anti-asthma drug inhaled from the Cyclohaler dry powder inhaler. Adv. Drug Deliv. Rev. 26 (1997) 59-67
2. Courrier H.M., Butz N., and Vandamme T.F. Pulmonary drug delivery systems: recent developments and prospects. Crit. Rev. Ther. Drug Carrier Syst. 19 (2002) 425-498
3. Korpáš J., and Honda Y. Aspects of airway defence mechanisms. Pathophysiology 3 (1996) 81-86
4. Kim C.S., and Folinsbee L.J. Physiological and biomechanical factors relevant to inhaled drug delivery. In: Adjei A.L., and Gupta P.K. (Eds). Inhalation Delivery of Therapeutic Peptides and Proteins vol. 107 (1997), Marcel Dekker, New York 1-25
5. Sebti T., and Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur. J. Pharm. Biopharm. 63 (2006) 51-58
6. Newman S.P., and Wilding I.R. Imaging techniques for assessing drug delivery in man. Pharm. Sci. Technol. Today 2 (1999) 181-189
7. Newman S.P., Pitcairn G.R., Hirst P.H., and Rankin L. Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs. Adv. Drug Deliv. Rev. 55 (2003) 851-867
8. Newman S.P., and Wilding R. Gamma scintigraphy: an in vivo technique for assessing the equivalence of inhaled products. Int. J. Pharm. 170 (1998) 1-9
9. Ball D.J., Hirst P.H., Newman S.P., Sonet B., Streel B., and Vanderbist F. Deposition and pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder device. Int. J. Pharm. 245 (2002) 123-132
10. Thorsson L., Newman S.P., Weisz A., Trofast E., and Moren F. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology 31 (1993) 7-10
11. Pedersen S., Steffensen G., and Ohlsson S.V. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. Br. J. Clin. Pharmacol. 36 (1993) 211-214
12. Thorsson L., Edsbacker S., and Conradson T.B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur. Respir. J. 7 (1994) 1839-1844
13. Quanjer P.H. Standardised lung function testing. Bull. Eur. Physiopathol. Respir. 19 (1983) 1-95
14. Newman S.P., Morén F., Trofast E., Talaee N., and Clarke S.W. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur. Respir. J. 2 (1989) 247-252
15. Newman S.P., Hirst P.H., Pitcairn G.R., and Clark A.R. Understanding regional lung deposition data in gamma scintigraphy. In: Dalby R.N., Byron P.R., and Farr S.J. (Eds). Respiratory Drug Delivery vol. VI (1998), Interpharm Press, Buffalo, Grove 9-15
16. Newman S.P., Pitcairn G.R., and Hirst P.H. A brief history of gamma scintigraphy. J. Aerosol Med. 14 (2001) 139-145
17. Dolovich M. Practical aspects of imaging techniques employed to study aerosol deposition and clearance. In: Hickey A.J. (Ed). Pharmaceutical Inhalation Aerosol Technology. second ed., revised and expanded vol. 134 (2004), Marcel Dekker, New York 171-213
18. Pitcairn G.R., and Newman S.P. Tissue attenuation corrections in gamma scintigraphy. J. Aerosol Med. 3 (1997) 187-198
19. Hirst R.H., Newman S.R., Clark D.A., and Hertog M.G. Lung deposition of budesonide from the novel dry powder inhaler Airmax. Respir. Med. 96 (2002) 389-396